Procedimientos, técnicas y comunicaciones en anestesiología, psiquiatría y medicina interna Consideraciones anestesiológicas para el trasplante renal
Contenido principal del artículo
Resumen
Los pacientes con insuficiencia renal crónica terminal (IRCT), de diferente etiología son considerados candidatos para trasplante renal. Los receptores entre 16 y 45 años de edad, con enfermedad renal primaria, tienen las tasas de morbilidad y mortalidad más bajas. Los de mayor edad con enfermedad cardiovascular son los de mayor riesgo, y sólo son considerados para trasplante en base a evaluaciones individuales.2,9 La enfermedad renal terminal, puede ser de origen primario o como resultado de enfermedades preexistentes. En cualquier caso la alteración de múltiples órganos estará presente.
Aspectos patológicos de la insuficiencia renal crónica terminal.
Detalles del artículo
Cómo citar
Referencias
Bower S. Plasma protein binding of fentanyl: the effect of hyperlipoproteinemia and chronic renal failure. J Pharm Pharmacol 1982; 34: 102.
Bready L. Kidney transplantation. Anesth Clin North Am 1989; 7: 487.
Carlier M, Squifflet JP, Pirson Y et al. Confirmation of the crucial role of the recipient’s maximal hydration on early diuresis of the human cadaver renal allograft. Transplantation 1983; 36: 455.
Cronnelly R, Stansky DR, Miller RD et al. Renal function and the pharmacokinetics of neostigmine in anesthetized man. Anesthesiology 1979; 51: 222.
DiMinno G, Martinez J, McKeann M et al. Platelet dysfunction in uremia: multifaceted defect partially corrected by dialysis. Am J Med 1985; 79: 552.
Don HF, Dreppa RA, Taylor R. Narcotic analgesics in anuric patients. Anesthesiology 1975; 42: 745.
Fahey MR, Rupp SM, Fisher DM et al. The pharmacokinetics and pharmacodynamics of atracurium in patients with and without renal failure. Anesthesiology 1984; 61: 699.
Fennell R, Rasbury W, Fennell E et al. Effects of kidney transplantation on cognitive performance in a pediatric population. Pediatrics 1984; 74: 273.
Frey D, Matas A. Renal transplantation. Crit Care Clin 1990; 6: 899.
Ghoneim MM, Long JP. The interaction between magnesium and other neuromuscular blocking agents. Anesthesiology 1970; 32: 23.
Ghoneim MM, Pandya H. Plasma protein binding of thiopental in patients with impaired renal or hepatic function. Anesthesiology 1975; N42: 545.
Kaplan SA, Jack ML, Alexander K et al. Pharmacokinetic profile of diazepam in man following single intravenous and oral and chronic oral administration. J Pharm Sci 1973; 62: 1789.
Koide M, Waud BE. Serum potassium concentrations after succinylcholine in patients with renal failure. Anesthesiology 1972; 36: 142.
Linke CL, Merin RG. A regional anesthetic approach for renal transplantation. Anesth Analg 1976; 55: 69.
Logan DA, Howie HB, Crawford J. Anaesthesia and renal transplantation: 56 cases. Br J Anaesth 1974; 46: 69.
Marsland AR, Bradley JP. Anaesthesia for renal transplantation-5 years experience in a regional transplantation center. Anaesth Intensive Care 1983; 11: 337.
Munda R, Alexander JW, First MR et al. Pulmonary infections in renal transplant recipients. Ann Surg 1978; 187: 126.
Opelz G, Teresaki PI. Improvement of kidney graft survival with increased numbers of blood transfusion. N Engl J Med 1978; 299: 799.
Powell DR, Miller RD. The effect of repeated dose of succinylcholine on serum potassium in patients with renal failure. Anesth Analg 1975; 54: 746.
Schaefer R, Horl W. Treatment of renal anemia recombinant human erythropoietin. Am J Nephrol 1989; 9: 353.
Vinik HR, Reyes JG, Greenblatt DJ et al. The pharmacokinetics of midazolam in chronic renal failure patients. Anesthesiology 1983; 59: 390.
Wickstrom I. Enflurane anesthesia in living donor renal transplantation. Acta Anaesthesiol Scand 1981; 25: 263.